Leap Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Cypherpunk Technologies

11/03/2022 13:26

* Leap Therapeutics Inc  LPTX.OQ  reported a quarterly
adjusted
loss of 10 cents​​ per share for the quarter ended in December.
The mean expectation of five analysts for the quarter was for a
loss of 11 cents per share.
    * Revenue held steady 0% to $375.00 thousand from a year
ago; 
analysts expected $306.00 thousand. 
    * Leap Therapeutics Inc's reported EPS for the quarter was a
loss
of 10 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Leap Therapeutics Inc shares had fallen by 46.0% this
quarter.
    * The company reported a quarterly loss of $10.79 million.
    * Wall Street's median 12-month price target for Leap
Therapeutics
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 11 at 01:26 p.m.  ​All
figures in US dollars unless otherwise stated